Mostra i principali dati dell'item

dc.creatorNtaios G., Korompoki E.en
dc.date.accessioned2023-01-31T09:40:32Z
dc.date.available2023-01-31T09:40:32Z
dc.date.issued2022
dc.identifier10.1016/j.ejim.2022.02.016
dc.identifier.issn09536205
dc.identifier.urihttp://hdl.handle.net/11615/77275
dc.description.abstract[No abstract available]en
dc.language.isoenen
dc.sourceEuropean Journal of Internal Medicineen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85124911139&doi=10.1016%2fj.ejim.2022.02.016&partnerID=40&md5=cc0c171007059a3055b0d5eaa4a22c3f
dc.subjectfibrinolytic agenten
dc.subjectcerebrovascular accidenten
dc.subjectcomplicationen
dc.subjectheart diseaseen
dc.subjecthumanen
dc.subjectsecondary preventionen
dc.subjectEmbolic Strokeen
dc.subjectFibrinolytic Agentsen
dc.subjectHeart Diseasesen
dc.subjectHumansen
dc.subjectSecondary Preventionen
dc.subjectStrokeen
dc.subjectElsevier B.V.en
dc.titleEmbolic stroke of undetermined source and atrial cardiopathy: Towards a personalized antithrombotic strategy for secondary stroke preventionen
dc.typeotheren


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item